FDA — authorised 14 November 1956
- Marketing authorisation holder: SANOFI AVENTIS US
- Status: approved
🇺🇸 Cantil in United States
FDA authorised Cantil on 14 November 1956
Marketing authorisations
FDA — authorised 14 November 1956
- Application: NDA010679
- Marketing authorisation holder: SANOFI AVENTIS US
- Local brand name: CANTIL
- Indication: SOLUTION — ORAL
- Status: approved
Cantil in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Gastroenterology approved in United States
Frequently asked questions
Is Cantil approved in United States?
Yes. FDA authorised it on 14 November 1956; FDA authorised it on 14 November 1956.
Who is the marketing authorisation holder for Cantil in United States?
SANOFI AVENTIS US holds the US marketing authorisation.